Not precisely. Although equally focus on GLP-one receptors, Tirz also activates GIP receptors, which makes it a twin agonist. This broader system is thought to boost its results on insulin sensitivity and hunger signaling in investigation products. Furthermore, early-phase study indicates probable protective outcomes on pancreatic islet construction and function https://peptisell.com/product/tirzepatide